Cephalosporin antibiotic drug product of Hanmi Pharmaceutical enters into the European market for the nation's first time

Published: 2014-07-01 15:54:47

Updated: 2014-07-01 16:01:40

Cephalosporin antibiotic drug product of Hanmi Pharmaceutical enters into the European market for the nation's first time.

On June 29, Hanmi Pharmaceutical announced that they received final marketing authorization of cephalosporin antibiotic 'Triaxon 1g injection' from the four countries in Europe.

The drug approval was acquired through German Federal Institute for Drugs and Medical Devices ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.